Cvi Holdings, LLC Cel Sci Corp Transaction History

Cvi Holdings, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$1.63 - $3.08 $1.43 Million - $2.71 Million	878,767 New	878,767 $1.68 Million
Q3 2018 Nov 14, 2018	SELL	$0.83 - $4.16 $664,834 - $3.33 Million	-801,006 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$0.92 - $3.5 $736,925 - $2.8 Million	801,006 New	801,006 $737,000

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cvi Holdings, LLC with notifications on news.